Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom Species

Mushrooms are widely-consumed fungi which contain natural compounds that can be used both for their nutritive and medicinal properties, i.e., taking advantage of their antimicrobial, antiviral, antitumor, anti-allergic, immunomodulation, anti-inflammatory, anti-atherogenic, hypoglycemic, hepatoprotective and antioxidant effects. Currently, scientific interest in natural compounds extracted from the fungal species is increasing because these compounds are also known to have pharmacological/biological activity. Unfortunately, however, their mechanisms of action are often unknown, not well understood or have not been investigated in their entirety. Given the poly-pharmacological properties of bioactive fungal compounds, it was decided to carry out a multi-targeted approach to predict possible interactions occurring among bioactive natural fungal extracts and several macromolecular targets that are therapeutically interesting, i.e., proteins, enzymes and nucleic acids. A chemical database of compounds extracted from both edible and no-edible mushrooms was created. This database was virtually screened against 43 macromolecular targets downloaded from the Protein Data Bank website. The aim of this work is to provide a molecular description of the main interactions involving ligand/multi-target recognition in order to understand the polypharmacological profile of the most interesting fungal extracts and to suggest a design strategy of new multi-target agents.

[1]  P. Sun,et al.  Extraction, Antimicrobial, and Antioxidant Activities of Crude Polysaccharides from the Wood Ear Medicinal Mushroom Auricularia auricula-judae (Higher Basidiomycetes). , 2015, International journal of medicinal mushrooms.

[2]  J. Zhong,et al.  Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. , 2009, Advances in biochemical engineering/biotechnology.

[3]  T. Mizuno The Extraction and Development of Antitumor-Active Polysaccharides from Medicinal Mushrooms in Japan (Review) , 1999 .

[4]  V. Sabaratnam,et al.  Therapeutic potential of culinary-medicinal mushrooms for the management of neurodegenerative diseases: diversity, metabolite, and mechanism , 2015, Critical reviews in biotechnology.

[5]  Kenjiro Ono,et al.  Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro , 2004, Journal of neuroscience research.

[6]  A. Jain,et al.  Medicinal mushrooms: Towards a new horizon , 2010, Pharmacognosy reviews.

[7]  T. Makino,et al.  Anti-allergic constituents in the culture medium ofGanoderma lucidum. (II) The inhibitory effect of cyclooctasulfur on histamine release , 1988, Agents and Actions.

[8]  R. Peralta,et al.  Hepatoprotective Effects of Mushrooms , 2013, Molecules.

[9]  T. Suga,et al.  Macrophage-mediated acute-phase transport protein production induced by lentinan. , 1986, International journal of immunopharmacology.

[10]  Shu-Ting Chang,et al.  Mushroom biology — A new discipline , 1992 .

[11]  J. Medina-Franco,et al.  Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.

[12]  Hua-Bin Li,et al.  Bioactivities and Health Benefits of Mushrooms Mainly from China , 2016, Molecules.

[13]  Yong-Mei Liu,et al.  Anti-inflammation and antioxidant effect of Cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis, in middle cerebral artery occlusion-induced focal cerebral ischemia in rats , 2012, Metabolic Brain Disease.

[14]  Solomon P. Wasser,et al.  Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives (review). , 1999 .

[15]  Vincenza Andrisano,et al.  Rational approach to discover multipotent anti-Alzheimer drugs. , 2005, Journal of medicinal chemistry.

[16]  H. Yonekawa,et al.  Genetic control of the expression of two biological activities of an antitumor polysaccharide, lentinan. , 1991, International journal of immunopharmacology.

[17]  Hong-yu Zhang One‐compound‐multiple‐targets strategy to combat Alzheimer's disease , 2005, FEBS letters.

[18]  J. Baell,et al.  Chemistry: Chemical con artists foil drug discovery , 2014, Nature.

[19]  Serge Eifes,et al.  Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment , 2010, Toxins.

[20]  Kenneth M Merz,et al.  The Ecstasy and Agony of Assay Interference Compounds. , 2017, ACS medicinal chemistry letters.

[21]  S. Wasser Wasser Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides , 2022 .

[22]  V. Pillay,et al.  Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. , 2016, Drug discovery today.

[23]  J. Mau,et al.  Antioxidant properties of several medicinal mushrooms. , 2002, Journal of agricultural and food chemistry.

[24]  T. Ng,et al.  Hypsin, a novel thermostable ribosome-inactivating protein with antifungal and antiproliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus. , 2001, Biochemical and biophysical research communications.

[25]  H. Ou,et al.  In Vivo and In Vitro Anti-Tumor Effects of Fungal Extracts , 2014, Molecules.

[26]  G. Chihara,et al.  Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). , 1970, Cancer research.

[27]  W. Breene Nutritional and Medicinal Value of Specialty Mushrooms. , 1990, Journal of food protection.

[28]  H. Tazaki,et al.  Anticancer and Hypoglycemic Effects of Polysaccharides in Edible and Medicinal Maitake Mushroom [ Grifola frondosa (Dicks.: Fr.) S. F. Gray] , 2002 .

[29]  Shu-Hui Hu,et al.  Antitumor and immunoenhancing activities of polysaccharide from culture broth of Hericium spp. , 2001, The Kaohsiung journal of medical sciences.

[30]  T. Anke,et al.  Pterulinic acid and pterulone, two novel inhibitors of NADH:ubiquinone oxidoreductase (complex I) produced by a Pterula species. I. Production, isolation and biological activities. , 1997, The Journal of antibiotics.

[31]  R. Herberman,et al.  The effect of lentinan on production of interleukin-1 by human monocytes. , 1982, Immunopharmacology.

[32]  G. Christie,et al.  A Case for Caution in Assessing the Antibiotic Activity of Extracts of Culinary-Medicinal Shiitake Mushroom [ Lentinus edodes (Berk.) Singer] (Agaricomycetideae) , 2003 .

[33]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[34]  D. Hawksworth Mushrooms: The Extent of the Unexplored Potential , 2001 .

[35]  Tatsuo Watanabe,et al.  Isolation and identification of a humanTRPV1 activating compound from soy sauce , 2017, Bioscience, biotechnology, and biochemistry.

[36]  Oliver Werz,et al.  Multi-target approach for natural products in inflammation. , 2014, Drug discovery today.

[37]  Polypharmacology in drug discovery Polypharmacology in drug discovery , 2015 .

[38]  Hongbin Sun,et al.  Synthesis, Biology and Clinical Significance of Pentacyclic Triterpenes: A Multi‐Target Approach to Prevention and Treatment of Metabolic and Vascular Diseases , 2011 .

[39]  D. H. Kim,et al.  Anti-Oxidant and Anti-Inflammatory Activities of Inonotus obliquus and Germinated Brown Rice Extracts , 2013, Molecules.

[40]  S. Franzblau,et al.  Antitubercular activity and inhibitory effect on Epstein-Barr virus activation of sterols and polyisoprenepolyols from an edible mushroom, Hypsizigus marmoreus. , 2005, Biological & pharmaceutical bulletin.

[41]  Kevin P. Sullivan,et al.  Economic Impacts of the Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank , 2017 .

[42]  Philip E. Bourne,et al.  The Research Collaboratory for Structural Bioinformatics Protein Data Bank , 2007 .

[43]  M L Bolognesi,et al.  Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease. , 1998, Journal of medicinal chemistry.

[44]  S. Kurashige,et al.  Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. , 1997, Immunopharmacology and immunotoxicology.

[45]  M. Beltran-Garcia,et al.  Volatile Compounds Secreted by the Oyster Mushroom (Pleurotus ostreatus) and Their Antibacterial Activities , 1997 .

[46]  P. Leeson,et al.  Drug discovery: Chemical beauty contest , 2012, Nature.

[47]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[48]  Rui M. V. Abreu,et al.  QCAR models to predict wild mushrooms radical scavenging activity, reducing power and lipid peroxidation inhibition , 2011 .

[49]  G. Chihara Recent progress in immunopharmacology and therapeutic effects of polysaccharides. , 1992, Developments in biological standardization.